- Featured Product
- KD/KO Validated
Dystroglycan Polyklonaler Antikörper
Dystroglycan Polyklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), IP, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 11017-1-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | HepG2-Zellen, HeLa-Zellen, Maushirngewebe, Maus-Skelettmuskelgewebe |
Erfolgreiche IP | Maushirngewebe |
Erfolgreiche Detektion in IHC | Mausherzgewebe, Maushirngewebe, Maus-Skelettmuskelgewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
Erfolgreiche Detektion in IF/ICC | HeLa-Zellen |
Erfolgreiche Detektion in FC (Intra) | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunhistochemie (IHC) | IHC : 1:50-1:500 |
Immunfluoreszenz (IF)/ICC | IF/ICC : 1:10-1:100 |
Durchflusszytometrie (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
WB | See 5 publications below |
IHC | See 4 publications below |
IF | See 1 publications below |
CoIP | See 1 publications below |
Produktinformation
11017-1-AP bindet in WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA Dystroglycan und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Maus, Ratte |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | Dystroglycan fusion protein Ag1456 |
Vollständiger Name | dystroglycan 1 (dystrophin-associated glycoprotein 1) |
Berechnetes Molekulargewicht | 97 kDa |
Beobachtetes Molekulargewicht | 40-43 kDa |
GenBank-Zugangsnummer | BC012740 |
Gene symbol | Dystroglycan |
Gene ID (NCBI) | 1605 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Dystroglycan, also known as DAG1 or DG, was originally isolated from skeletal muscle as an integral membrane component of the dystrophin-glycoprotein complex (DGC). In addition to skeletal muscle, dystroglycan is strongly expressed in heart and smooth muscle, as well as many non-muscle tissues including brain and peripheral nerve (PMID: 12556455). The dystroglycan is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization. Dystroglycan consists of two subunits (alpha and beta), which are translated from a single mRNA as a propeptide that is proteolytically cleaved into two noncovalently associated proteins (PMID: 16410545). Alpha-dystroglycan is a 156-kDa extracellular peripheral glycoprotein, while beta-dystroglycan is a 43-kDa transmembrane protein (PMID: 9858474). The 43-kDa beta-dystroglycan can be cleaved into a ~30-kDa form (PMID: 14678802; 18458097; 17255331).
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for Dystroglycan antibody 11017-1-AP | Protokoll herunterladen |
IHC protocol for Dystroglycan antibody 11017-1-AP | Protokoll herunterladen |
IF protocol for Dystroglycan antibody 11017-1-AP | Protokoll herunterladen |
IP protocol for Dystroglycan antibody 11017-1-AP | Protokoll herunterladen |
FC protocol for Dystroglycan antibody 11017-1-AP | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Nat Commun IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models. | ||
Transl Res AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase I deficiency (PGM1-CDG) | ||
Mol Oncol Circular RNA circ-TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR-452-5p/DAG1 axis | ||
Cell Commun Signal Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. | ||
Front Cardiovasc Med Determination of Agrin and Related Proteins Levels as a Function of Age in Human Hearts. | ||
J Med Virol Identification of potential plasma markers for hepatitis B virus-related chronic hepatitis and liver fibrosis/cirrhosis. |
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Perrin (Verified Customer) (11-22-2022) | Works very well, with little background
|
FH Ryan (Verified Customer) (01-10-2018) |
|